However, the synergy between MYC depletion and JQ1 inhibition in abolishing cellular movement also alludes to potentially unidentified mechanisms other than the MYC-RhoA axis in the JQ1-endued suppression of DLBCL migration. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.